Neola Medical AB (NEOLA) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.033x

Based on the latest financial reports, Neola Medical AB (NEOLA) has a cash flow conversion efficiency ratio of -0.033x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-2.57 Million ≈ $-277.00K USD) by net assets (Skr78.46 Million ≈ $8.44 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Neola Medical AB - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how Neola Medical AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Neola Medical AB carry for a breakdown of total debt and financial obligations.

Neola Medical AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Neola Medical AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Burford Capital Limited LSE:BUR	0.048x
Bawat Water Technologies AB ST:BAWAT	-3.748x
Memphasys Ltd AU:MEM	-0.306x
BOA Resources Ltd AU:BOA	-0.060x
Impax Environmental Markets PLC LSE:IEM	0.003x
UET United Electronic Technology AG XETRA:CFC	8.013x
InCoax Networks AB ST:INCOAX	-0.091x
Digjam Limited NSE:DIGJAMLMTD	0.069x

Annual Cash Flow Conversion Efficiency for Neola Medical AB (2018–2024)

The table below shows the annual cash flow conversion efficiency of Neola Medical AB from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see NEOLA market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr68.96 Million ≈ $7.42 Million	Skr-10.84 Million ≈ $-1.17 Million	-0.157x	-89.83%
2023-12-31	Skr79.03 Million ≈ $8.50 Million	Skr-6.54 Million ≈ $-704.02K	-0.083x	+34.25%
2022-12-31	Skr67.48 Million ≈ $7.26 Million	Skr-8.50 Million ≈ $-914.41K	-0.126x	+26.18%
2021-12-31	Skr40.63 Million ≈ $4.37 Million	Skr-6.93 Million ≈ $-745.89K	-0.171x	+33.89%
2020-12-31	Skr23.55 Million ≈ $2.53 Million	Skr-6.08 Million ≈ $-653.77K	-0.258x	-33.84%
2019-12-31	Skr10.72 Million ≈ $1.15 Million	Skr-2.07 Million ≈ $-222.44K	-0.193x	-94.79%
2018-12-31	Skr13.33 Million ≈ $1.43 Million	Skr-1.32 Million ≈ $-141.95K	-0.099x	--

About Neola Medical AB

ST:NEOLA Sweden Medical Devices

Market Cap

$10.07 Million

Skr93.54 Million SEK

Market Cap Rank

#26865 Global

#586 in Sweden

Share Price

Skr1.20

Change (1 day)

+3.45%

52-Week Range

Skr0.64 - Skr2.56

All Time High

Skr7.54